Responses
Scientific Abstracts
Poster Presentations
Posters
Other orphan diseases
THU0378 Interleukin-6 blocking therapy by tocilizumab in patients with multicentric castleman’s disease results in a significant decrease in serum levels of IgG4 and IGE
Compose a Response to This Article
Other responses
No responses have been published for this article.